Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PURE BiosciencePURE -7.01% 3-Year EBITDA Growth Rate is 19.90% as of Apr. 2026, which is at its 10-year median of 19.90. The stock has 5 warning signs investors should review. Among 1,675 Consumer Packaged Goods companies, PURE Bioscience ranks better than 69.13% on this metric.
During the past 3 years, the average EBITDA Per Share Growth Rate was 19.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of PURE Bioscience was 49.90% per year. The lowest was -20.50% per year. And the median was 19.90% per year.
PURE Bioscience (OTCPK:PURE) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
PURE Bioscience 3-Year EBITDA Growth Rate Related Terms
PURE vs DQWS, RAY, TANH: 3-Year EBITDA Growth Rate Comparison
For the Household & Personal Products subindustry, PURE Bioscience's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PURE Bioscience 3-Year EBITDA Growth Rate vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, PURE Bioscience's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where PURE Bioscience's 3-Year EBITDA Growth Rate falls into.
PURE Bioscience 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 19.90% mean?
PURE Bioscience (PURE) has a 3-Year EBITDA Growth Rate of 19.90% as of Apr. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for PURE Bioscience and its competitors. This is near median its historical median of 19.90. According to the industry distribution chart, PURE Bioscience ranks #517 out of 1675 companies in the Consumer Packaged Goods industry, placing it in the top 30.9%.
Is PURE Bioscience's 3-Year EBITDA Growth Rate too high?
PURE Bioscience's current 3-Year EBITDA Growth Rate of 19.90% is near median its 10-year median of 19.90. The Consumer Packaged Goods industry median 3-Year EBITDA Growth Rate is 8.20. PURE Bioscience's value of 19.90% is 142.7% above this industry median. Based on the distribution chart, PURE Bioscience ranks #517 out of 1675 companies in the Consumer Packaged Goods industry, which is above the industry midpoint.
How does PURE Bioscience's 3-Year EBITDA Growth Rate compare to DQWS and RAY?
According to the Consumer Packaged Goods industry distribution chart, PURE Bioscience ranks #517 out of 1675 companies for 3-Year EBITDA Growth Rate. This puts PURE Bioscience in the upper half of its industry. The industry median 3-Year EBITDA Growth Rate is 8.20. PURE Bioscience's value of 19.90% is 142.7% above this benchmark. While the company's 10-year median is 19.90 vs. the industry median of 8.20, PURE Bioscience has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Consumer Packaged Goods company?
The median 3-Year EBITDA Growth Rate among Consumer Packaged Goods companies is 8.20, based on 1,675 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PURE Bioscience's current 3-Year EBITDA Growth Rate of 19.90% is 142.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for PURE Bioscience and its competitors. For the Consumer Packaged Goods industry, the median 3-Year EBITDA Growth Rate is 8.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PURE Bioscience's current 3-Year EBITDA Growth Rate is 19.90%, which is near median its own 10-year median of 19.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PURE Bioscience stock overvalued right now?
Based on GuruFocus' analysis, PURE Bioscience (PURE) is currently considered Possible Value Trap. The stock's GF Value™ is $0.10, compared to a current price of $0.07 — trading 35% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 19.90%, which is near median its 10-year median of 19.90 and 142.7% above the Consumer Packaged Goods industry median of 8.20. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For PURE Bioscience (PURE), the current 3-Year EBITDA Growth Rate is 19.90% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PURE Bioscience Inc is engaged in developing and commercializing proprietary antimicrobial products. The company's technology platform is based on patented stabilized ionic silver, and its initial products contain silver dihydrogen citrate, or SDC. It offers PURE Hard Surface as a food contact surface sanitizer and disinfectant to restaurant chains, food processors and food transportation companies and PURE Control as a direct food contact processing aid. It also manufactures and sells SDC-based products for end use, and products preserved with SDC and SDC as a raw material ingredient for manufacturing use. The company generates revenue from the sale of its antimicrobial products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PURE has been successfully added to your 
